Skip to main content
. 2015 Jul 29;14:139. doi: 10.1186/s12943-015-0412-3

Fig. 5.

Fig. 5

SgK223 and EGFR signaling. a Effect of SgK223 overexpression on EGFR Y1068 phosphorylation and Grb2 expression. b Effect of SgK223 overexpression on additional EGFR tyrosine phosphorylation sites. Data are normalized and expressed as in the previous figs. c The EGFR inhibitor, erlotinib, does not affect Stat3 phosphorylation in SgK223-overexpressing cells